PESCITELLI, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 2.090
EU - Europa 1.174
AS - Asia 336
AF - Africa 17
OC - Oceania 12
Totale 3.629
Nazione #
US - Stati Uniti d'America 2.085
RU - Federazione Russa 459
PL - Polonia 264
IE - Irlanda 148
SG - Singapore 121
HK - Hong Kong 118
IT - Italia 110
SE - Svezia 110
CN - Cina 56
GB - Regno Unito 22
JO - Giordania 20
DE - Germania 19
FI - Finlandia 18
CI - Costa d'Avorio 16
AU - Australia 12
CH - Svizzera 9
UA - Ucraina 6
CA - Canada 5
IN - India 5
TR - Turchia 5
IR - Iran 4
VN - Vietnam 4
ES - Italia 2
FR - Francia 2
ID - Indonesia 2
LT - Lituania 2
BE - Belgio 1
KR - Corea 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
Totale 3.629
Città #
Santa Clara 763
Warsaw 264
Chandler 203
Dublin 148
Fairfield 144
Singapore 101
Hong Kong 84
Woodbridge 81
Lawrence 75
Altamura 73
Seattle 61
Ashburn 55
Wilmington 53
Cambridge 52
Houston 49
Princeton 41
Buffalo 40
Medford 40
Florence 20
Ann Arbor 19
Shanghai 19
Abidjan 16
San Diego 16
Kent 15
Jacksonville 13
Norwalk 12
Boardman 11
Moscow 11
Beijing 9
Melbourne 9
Boston 7
London 7
Bern 6
Izmir 5
Los Angeles 5
Andover 4
Guangzhou 4
Hillsboro 4
Yubileyny 4
Cagliari 3
El Paso 3
Falls Church 3
Frankfurt am Main 3
Lausanne 3
Mumbai 3
Ottawa 3
Saint Petersburg 3
Arezzo 2
Barcelona 2
Cento 2
Falkenstein 2
Helsinki 2
Jakarta 2
Laurel 2
Prescot 2
Redwood City 2
Reggio Emilia 2
Tappahannock 2
Toronto 2
West Bloomfield 2
Acton 1
Arnsberg 1
Basking Ridge 1
Bremen 1
Brussels 1
Chicago 1
Downers Grove 1
Gunzenhausen 1
Hanover 1
Islington 1
Ivanhoe 1
Monteriggioni 1
Munich 1
Nanjing 1
New Bedfont 1
Oslo 1
Phoenix 1
Rome 1
Rui'an 1
San Vito al Tagliamento 1
Seoul 1
Tehran 1
Trumbull 1
Wuhan 1
Totale 2.617
Nome #
The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin 253
Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. 220
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 166
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 159
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 138
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 122
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 117
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 115
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin. 109
Evidence for oxidative stress in the plasma of psoriatic patients: Source of ROS and results of treatments with biologics 101
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 100
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 89
Vitiligo masks malignant acanthosis nigricans in a woman with ovarian cancer 86
Source of oxidative stress in fibroblasts from patients affected by psoriasis 85
Reduction in psoriasis related pruritus during biologic therapy* 84
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients 84
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis 81
Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score 80
Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin 76
Clinical experience with infliximab biosimilar in psoriasis 76
Clinical characteristics of psoriasis in inflammatory bowel disease patients 75
Erythrodermic psoriasis treated with ustekinumab: An Italian multicenter retrospective analysis 74
Cutaneous hyperpigmentation induced by apremilast 74
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 73
First case of secukinumab successful therapy in a very elderly psoriatic patient 72
Hidradenitis suppurativa and associated diseases 72
A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy 71
Intellectual Disability and Hidradenitis Suppurativa 71
Oxidative stress in the pathogenesis of vitiligo 69
Ultrastructural mitochondrial alterations and oxidative damage in keratinocytes from perilesional vitiligo skin 68
Epidermal barrier reaction to an in vitro psoriatic microenvironment 67
Mitochondrial Damage and Apoptosis in Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin 63
Oxidative stress markers in psoriatic patients plasma and NADPH oxidase as a source of oxidative stress in fibroblasts 63
Vitiligo: Ultrastructure, oxidative stress and apoptosis in perilesional skin 62
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 62
Effect of a psoriatic microenvironment in a three-dimensional model of normal human skin 59
Novel therapeutic approaches and targets for the treatment of atopic dermatitis 58
Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature 55
The role of Smac/DIABLO, p53, NF-kB, and MAPKs in Apoptosis of Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin. 54
Tuberculosis reactivation risk in dermatology 54
Treatment of severe nail psoriasis with acitretin: An impressive therapeutic result 5
Totale 3.662
Categoria #
all - tutte 11.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 0 0 0 0 0 0 33 39 34 23 17 10
2020/2021186 19 17 13 17 7 20 5 22 17 24 12 13
2021/2022273 9 11 12 1 2 35 24 19 6 17 69 68
2022/2023778 64 188 42 54 62 141 75 40 75 2 19 16
2023/2024206 15 21 44 7 10 11 9 50 1 8 23 7
2024/20251.591 96 199 123 242 674 253 4 0 0 0 0 0
Totale 3.662